Fusion Pharm Equity 2024

Fusion Pharm Aktienanalyse

What does Fusion Pharm do?

Fusion Pharm Inc is a well-known company in the agricultural industry that operates in various business sectors. It was founded in 2010 by Scott Dittman with the idea of improving agricultural efficiency through the use of innovative technologies. Fusion Pharm has gradually built different business areas focused on the development and marketing of products for optimizing agriculture. One of Fusion Pharm's core areas is the production of modular cultivation systems for plants that utilize cutting-edge technologies. These systems, called "PharmaCubes," are designed to provide optimal conditions for plants and achieve higher crop yields. They are particularly intended for use in urban spaces and other environments where traditional cultivation methods may not be feasible. The advantage of these systems lies in their scalability, and they are optimized for indoor use. Another important business area for Fusion Pharm is the production of fertilizers and other agricultural chemicals. These products are marketed under the brand name "Agritabs" and are aimed at promoting healthier plant growth and higher crop yields. The agricultural chemicals are made from natural raw materials, making them more environmentally friendly than many other products on the market. They are intended for use in various industries, including agriculture, gardening and landscaping, and the food industry. In addition to manufacturing and supplying cultivation systems, Fusion Pharm also operates in the production and distribution of natural fertilizers and other agricultural chemicals. The company has also undertaken a pilot project for closed-room fish farming and established itself in the aquaculture industry. In recent years, the company has pursued an aggressive acquisition strategy to expand into new business fields. One of these acquisitions was the takeover of the cloud-based software company "CannaCube," which has developed a management system for cannabis cultivation. Through the acquisition of CannaCube, Fusion Pharm has now positioned its portfolio for the growing cannabis industry. The company has made a name for itself in the agricultural industry by optimizing existing processes for sustainable and efficient plant development. With its innovative technology and products, the company contributes to greater efficiency and a more environmentally friendly agricultural industry. Fusion Pharm ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Fusion Pharm's Equity

Fusion Pharm's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Fusion Pharm's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Fusion Pharm's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Fusion Pharm's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Fusion Pharm’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Fusion Pharm stock

What is the equity of Fusion Pharm this year?

Fusion Pharm has equity of 0 USD this year.

What was the equity of Fusion Pharm compared to the previous year?

The equity of Fusion Pharm has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Fusion Pharm?

A high equity is advantageous for investors of Fusion Pharm as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Fusion Pharm?

A low equity can be a risk for investors of Fusion Pharm, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Fusion Pharm affect the company?

An increase in equity of Fusion Pharm can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Fusion Pharm affect the company?

A reduction in equity of Fusion Pharm can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Fusion Pharm?

Some factors that can affect the equity of Fusion Pharm include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Fusion Pharm so important for investors?

The equity of Fusion Pharm is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Fusion Pharm take to change the equity?

To change equity, Fusion Pharm can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Fusion Pharm pay?

Over the past 12 months, Fusion Pharm paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Fusion Pharm is expected to pay a dividend of 0 USD.

What is the dividend yield of Fusion Pharm?

The current dividend yield of Fusion Pharm is .

When does Fusion Pharm pay dividends?

Fusion Pharm pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Fusion Pharm?

Fusion Pharm paid dividends every year for the past 0 years.

What is the dividend of Fusion Pharm?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Fusion Pharm located?

Fusion Pharm is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Fusion Pharm kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fusion Pharm from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Fusion Pharm pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Fusion Pharm in the year 2023?

In the year 2023, Fusion Pharm distributed 0 USD as dividends.

In which currency does Fusion Pharm pay out the dividend?

The dividends of Fusion Pharm are distributed in USD.